Azithramycine

Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.

Cross Reference

Introduction

To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Azithramycine?

Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Azithramycine

MeSH term MeSH ID Detail
Pneumocystis Infections D016720 1 associated lipids
Corneal Endothelial Cell Loss D055954 1 associated lipids
Male Urogenital Diseases D052801 1 associated lipids
Trichiasis D058457 1 associated lipids
Reproductive Tract Infections D060737 1 associated lipids
Frontal Sinusitis D015522 1 associated lipids
Asymptomatic Infections D058345 1 associated lipids
Hyper-IgM Immunodeficiency Syndrome D053306 1 associated lipids
Paratyphoid Fever D010284 1 associated lipids
Aphasia, Broca D001039 1 associated lipids
T-Lymphocytopenia, Idiopathic CD4-Positive D018344 1 associated lipids
Ectodermal Dysplasia D004476 1 associated lipids
Acquired Hyperostosis Syndrome D020083 1 associated lipids
Tick Bites D064927 1 associated lipids
Eisenmenger Complex D004541 1 associated lipids
Myelitis, Transverse D009188 1 associated lipids
Epiglottitis D004826 1 associated lipids
Granulomatous Mastitis D058890 1 associated lipids
Focal Nodular Hyperplasia D020518 1 associated lipids
Furcation Defects D017823 1 associated lipids
Syncope, Vasovagal D019462 1 associated lipids
Pseudolymphoma D019310 1 associated lipids
Achondroplasia D000130 1 associated lipids
Leishmaniasis, Mucocutaneous D007897 1 associated lipids
Trismus D014313 1 associated lipids
Tracheobronchomalacia D055089 1 associated lipids
Pericoronitis D010497 2 associated lipids
Lung Diseases, Parasitic D008174 2 associated lipids
Tuberculosis, Urogenital D014401 2 associated lipids
Granuloma Inguinale D006100 2 associated lipids
Chlamydiaceae Infections D002694 2 associated lipids
Chlamydial Pneumonia D061387 2 associated lipids
Toxoplasmosis, Ocular D014126 2 associated lipids
Nasopharyngeal Diseases D009302 2 associated lipids
Pneumonia, Lipid D011017 2 associated lipids
Abdominal Abscess D018784 2 associated lipids
Typhoid Fever D014435 2 associated lipids
Furunculosis D005667 2 associated lipids
Heartburn D006356 2 associated lipids
Pyomyositis D052880 2 associated lipids
Tooth Erosion D014077 2 associated lipids
Pyloric Stenosis, Hypertrophic D046248 2 associated lipids
Hearing Loss, Conductive D006314 2 associated lipids
Elephantiasis D004604 2 associated lipids
Multiple Pulmonary Nodules D055613 2 associated lipids
Tooth Mobility D014086 2 associated lipids
Hoarseness D006685 2 associated lipids
Granuloma, Pyogenic D017789 2 associated lipids
Toxoplasmosis, Congenital D014125 2 associated lipids
Bites, Human D001734 2 associated lipids
Per page 10 20 50 100 | Total 276

PubChem Associated disorders and diseases

What pathways are associated with Azithramycine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Azithramycine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Azithramycine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Azithramycine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Azithramycine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Azithramycine?

Mouse Model

Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).

Knock-out

Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).

Tissue Model

Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Azithramycine

Download all related citations
Per page 10 20 50 100 | Total 4404
Authors Title Published Journal PubMed Link
Vallejo C et al. Resolution of cyclosporine-induced gingival hyperplasia resistant to azithromycin by switching to tacrolimus. 2001 Haematologica pmid:11146586
Cascaval RI and Lancaster DJ Hypersensitivity syndrome associated with azithromycin. 2001 Am. J. Med. pmid:11247598
Urbano F and Urbano P Azithromycin in healthy adults? 2001 Clin. Microbiol. Infect. pmid:11531993
Miyazaki S et al. Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice. 2001 J. Antimicrob. Chemother. pmid:11533011
Milkovic-Kraus S and Kanceljak-Macan B Occupational airborne allergic contact dermatitis from azithromycin. 2001 Contact Derm. pmid:11553158
Gray GC and Ryan MA Azithromycin chemoprophylaxis. 2001 J. Infect. Dis. pmid:11494171
Chodorowska M et al. [Susceptibility to macrolide antibiotics of Bordetella pertussis and Bordetella parapertussis strains isolated from whooping cough patients in 1968 and in 1997-99]. 2001 Med Dosw Mikrobiol pmid:11757403
Jacks S et al. Pharmacokinetics of azithromycin and concentration in body fluids and bronchoalveolar cells in foals. 2001 Am. J. Vet. Res. pmid:11763173
Kays MB and Denys GA In vitro activity and pharmacodynamics of azithromycin and clarithromycin against Streptococcus pneumoniae based on serum and intrapulmonary pharmacokinetics. 2001 Clin Ther pmid:11318076
Dinos GP et al. Insights into the mechanism of azithromycin interaction with an Escherichia coli functional ribosomal complex. 2001 Mol. Pharmacol. pmid:11353804
Gupta S et al. Pharmacokinetic and safety profile of desloratadine and fexofenadine when coadministered with azithromycin: a randomized, placebo-controlled, parallel-group study. 2001 Clin Ther pmid:11318079
Parsad D et al. Azithromycin monthly pulse vs daily doxycycline in the treatment of acne vulgaris. 2001 J. Dermatol. pmid:11280457
Waring AL et al. Development of a genomics-based PCR assay for detection of Mycoplasma pneumoniae in a large outbreak in New York State. 2001 J. Clin. Microbiol. pmid:11283060
Chetchotisakd P et al. Maintenance therapy of melioidosis with ciprofloxacin plus azithromycin compared with cotrimoxazole plus doxycycline. 2001 Jan-Feb Am. J. Trop. Med. Hyg. pmid:11425157
Baumann U et al. Buccal adherence of Pseudomonas aeruginosa in patients with cystic fibrosis under long-term therapy with azithromycin. 2001 Jan-Feb Infection pmid:11261763
Kent JR et al. Azithromycin: an assessment of its pharmacokinetics and therapeutic potential in CAPD. 2001 Jul-Aug Perit Dial Int pmid:11587400
Gakiya E et al. [Experimental infection in mice by Plasmodium berghei: an evidence of antiparasitic action of azithromycin]. 2001 Mar-Apr Rev. Soc. Bras. Med. Trop. pmid:11391444
Lorenz J et al. Treatment outcomes in acute exacerbations of chronic bronchitis: comparison of macrolides and moxifloxacin from the patient perspective. 2001 Mar-Apr J. Int. Med. Res. pmid:11393351
Postma MJ et al. Cost-effectiveness of partner pharmacotherapy in screening women for asymptomatic infection with Chlamydia Trachomatis. 2001 May-Jun Value Health pmid:11705188
Akritopoulou-Zanze I and Sowin TJ Solid-phase synthesis of macrolide analogues. 2001 May-Jun J Comb Chem pmid:11350254
Aberg JA et al. Presence of macrolide resistance in respiratory flora of HIV-Infected patients receiving either clarithromycin or azithromycin for Mycobacterium avium complex prophylaxis. 2001 Nov-Dec HIV Clin Trials pmid:11742432
Biswas S In-vitro antimalarial activity of azithromycin against chloroquine sensitive and chloroquine resistant Plasmodium falciparum. 2001 Oct-Dec J Postgrad Med pmid:11832638
Pukrittayakamee S et al. Therapeutic responses to antibacterial drugs in vivax malaria. 2001 Sep-Oct Trans. R. Soc. Trop. Med. Hyg. pmid:11706666
Schilling F and Kessler S [Chronic recurrent multifocal osteomyelitis-- I. Review]. 2001 Sep-Oct Klin Padiatr pmid:11582525
Schilling F et al. [Pelvic type of chronic recurrent multifocal osteomyelitis]. 2001 Sep-Oct Klin Padiatr pmid:11582526
Dubois J and St-Pierre C In vitro susceptibility study of BMS-284756 against Legionella species. 2001 Sep-Oct Diagn. Microbiol. Infect. Dis. pmid:11687318
Esteban J et al. A comparison between disk diffusion and microdilution for susceptibility testing of Mycobacterium fortuitum complex. 2002 J Chemother pmid:12583544
Williams K Patient-delivered therapy: an additional means for addressing the Chlamydia trachomatis problem. 2002 Tenn Med pmid:12491815
Ranque S et al. Triangular test applied to the clinical trial of azithromycin against relapses in Plasmodium vivax infections. 2002 Malar. J. pmid:12473182
Allam AF and Shehab AY Efficacy of azithromycin, praziquantel and mirazid in treatment of cryptosporidiosis in school children. 2002 J Egypt Soc Parasitol pmid:12512828
Bogomil'skiÄ­ MP and Komarov RM [Azithromycin in the treatment of acute otitis media]. 2002 Antibiot. Khimioter. pmid:12515096
Hand WI and Hand DL [Mechanisms of azithromycin accumulation and efflux in human polymorphonuclear leukocytes]. 2002 Antibiot. Khimioter. pmid:12516190
Di Paolo A et al. Pharmacokinetics of azithromycin in lung tissue, bronchial washing, and plasma in patients given multiple oral doses of 500 and 1000 mg daily. 2002 Pharmacol. Res. pmid:12457629
Chiu LM et al. Pharmacokinetics of intravenous azithromycin and ceftriaxone when administered alone and concurrently to healthy volunteers. 2002 J. Antimicrob. Chemother. pmid:12461037
Hauke W et al. Esberitox N as supportive therapy when providing standard antibiotic treatment in subjects with a severe bacterial infection (acute exacerbation of chronic bronchitis). A multicentric, prospective, double-blind, placebo-controlled study. 2002 Chemotherapy pmid:12476043
Kamau FN et al. Isocratic liquid chromatographic method for the analysis of azithromycin and its structurally related substances in bulk samples. 2002 J Chromatogr Sci pmid:12433117
Tyteca D et al. Azithromycin, a lysosomotropic antibiotic, has distinct effects on fluid-phase and receptor-mediated endocytosis, but does not impair phagocytosis in J774 macrophages. 2002 Exp. Cell Res. pmid:12441132
Aguirrebengoa K et al. [Endocarditis due to Bartonella henselae on a native valve. A new case with some notable aspects]. 2002 Enferm. Infecc. Microbiol. Clin. pmid:12372243
Blondeau JM The evolution and role of macrolides in infectious diseases. 2002 Expert Opin Pharmacother pmid:12150692
Khan WA et al. Comparison of single-dose azithromycin and 12-dose, 3-day erythromycin for childhood cholera: a randomised, double-blind trial. 2002 Lancet pmid:12480424
Weiss LM Babesiosis in humans: a treatment review. 2002 Expert Opin Pharmacother pmid:12150690
Rao RU et al. Brugia malayi: effects of antibacterial agents on larval viability and development in vitro. 2002 Exp. Parasitol. pmid:12243742
Pastor E et al. [Macrolide consumption according to geographic areas in the province of Valladolid]. 2002 Enferm. Infecc. Microbiol. Clin. pmid:12433351
Matute AJ et al. Double-blind, placebo-controlled study comparing the effect of azithromycin with clarithromycin on oropharyngeal and bowel microflora in volunteers. 2002 Eur. J. Clin. Microbiol. Infect. Dis. pmid:12111597
Williams ES and Miller JM Results from late-breaking clinical trial sessions at the American College of Cardiology 51st Annual Scientific Session. 2002 J. Am. Coll. Cardiol. pmid:12113263
Kopjar B Azithromycin is effective in patients with chronic bronchitis. 2002 J. Antimicrob. Chemother. pmid:12205072
Baschiera F et al. Improved tonsillar disposition of azithromycin following a 3-day oral treatment with 20 mg kg(-1) in paediatric patients. 2002 Pharmacol. Res. pmid:12208127
Maizumi N et al. Quantitative comparison of the cytocidal effect of seven macrolide antibiotics on human periodontal ligament fibroblasts. 2002 J. Periodont. Res. pmid:12200967
House D et al. Cytokine release by lipopolysaccharide-stimulated whole blood from patients with typhoid fever. 2002 J. Infect. Dis. pmid:12134261
Paladino JA et al. Cost-effectiveness of IV-to-oral switch therapy: azithromycin vs cefuroxime with or without erythromycin for the treatment of community-acquired pneumonia. 2002 Chest pmid:12377852
Wallace Jr RJ et al. Repeat positive cultures in Mycobacterium intracellulare lung disease after macrolide therapy represent new infections in patients with nodular bronchiectasis. 2002 J. Infect. Dis. pmid:12134265
Cheng H et al. Synthesis and SAR of azalide 3,6-ketal aromatic derivatives as potent Gram-positive and Gram-negative antibacterial agents. 2002 Bioorg. Med. Chem. Lett. pmid:12161150
Kawashima M et al. Inhibitory effects of 14-membered ring macrolide antibiotics on bleomycin-induced acute lung injury. 2002 Lung pmid:12182159
Yee CL et al. Tendon or joint disorders in children after treatment with fluoroquinolones or azithromycin. 2002 Pediatr. Infect. Dis. J. pmid:12182376
Clark C et al. In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin. 2002 Antimicrob. Agents Chemother. pmid:12183253
Blandizzi C et al. Distribution of azithromycin in plasma and tonsil tissue after repeated oral administration of 10 or 20 milligrams per kilogram in pediatric patients. 2002 Antimicrob. Agents Chemother. pmid:11959610
Ekici A et al. Effect of azithromycin on the severity of bronchial hyperresponsiveness in patients with mild asthma. 2002 J Asthma pmid:11990233
Mohler AM Treatment of streptococcal pharyngitis. 2002 Am Fam Physician pmid:11996411
Cohen R et al. Comparison of two dosages of azithromycin for three days versus penicillin V for ten days in acute group A streptococcal tonsillopharyngitis. 2002 Pediatr. Infect. Dis. J. pmid:12075760
Schaad UB et al. Azithromycin versus penicillin V for treatment of acute group A streptococcal pharyngitis. 2002 Pediatr. Infect. Dis. J. pmid:12075761
Domeika M et al. Chlamydia trachomatis infections in eastern Europe: legal aspects, epidemiology, diagnosis, and treatment. 2002 Sex Transm Infect pmid:12081171
Patrick DM et al. Heterosexual outbreak of infectious syphilis: epidemiological and ethnographic analysis and implications for control. 2002 Sex Transm Infect pmid:12083438
Campos-Outcalt D et al. Use of directly observed azithromycin treatment for syphilis in a homeless woman. 2002 Sex Transm Dis pmid:12035029
Lisby JG et al. [Bacteremia and meningitis caused by Streptococcus pneumoniae during treatment with azithromycin]. 2002 Ugeskr. Laeg. pmid:12043408
Nishikawa T [Comment on the contribution by Weigl CB et al. "Papillomatosis confluens et reticularis"]. 2002 Hautarzt pmid:12063751
Batieha A et al. No advantage of treating acute respiratory tract infections with azithromycin in a placebo-controlled study. 2002 Scand. J. Infect. Dis. pmid:12064684
Carryn S et al. Comparative intracellular (THP-1 macrophage) and extracellular activities of beta-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations. 2002 Antimicrob. Agents Chemother. pmid:12069960
Babl FE et al. Experimental acute otitis media due to nontypeable Haemophilus influenzae: comparison of high and low azithromycin doses with placebo. 2002 Antimicrob. Agents Chemother. pmid:12069974
Chimura T [Changes of antibody titers during antimicrobial therapy including levofloxacin for Chlamydia infections in the obstetrics and gynecology field]. 2002 Jpn J Antibiot pmid:12071097
Reshetniak VI et al. [Eradication of Helicobacter pylori in patients with duodenal ulcer following the short course of treatment with azitromycin and amoxycillin]. 2002 Antibiot. Khimioter. pmid:12087718
Kays MB et al. Azithromycin treatment failure in community-acquired pneumonia caused by Streptococcus pneumoniae resistant to macrolides by a 23S rRNA mutation. 2002 Diagn. Microbiol. Infect. Dis. pmid:12088625
Breier AR et al. Microbiological assay for azithromycin in pharmaceutical formulations. 2002 J Pharm Biomed Anal pmid:12093530
Stone AF et al. Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA). 2002 Circulation pmid:12208796
Sirois F [Delirium associated with azithromycin administration]. 2002 Can J Psychiatry pmid:12211892
Fraser-Hurt N and Mabey D Trachoma. 2002 Clin Evid pmid:12230687
Frank E et al. A multicenter, open-label, randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia. 2002 Clin Ther pmid:12240780
Shor A Atherosclerosis: lipid infiltration or Chlamydia pneumoniae infection? 2002 Circulation pmid:12403680
Orfila J et al. [Systematic screening for Chlamydia trachomatis with the molecular biological AMP-CT test in urine samples from young women]. 2002 J Gynecol Obstet Biol Reprod (Paris) pmid:12407326
Krolewiecki A et al. Activity of azithromycin against Leishmania major in vitro and in vivo. 2002 Am. J. Trop. Med. Hyg. pmid:12408666
Ortega E et al. In vitro and ex vivo effects of erythromycin A, azithromycin and josamycin on the splenic response to specific antigens and mitogens. 2002 J. Antimicrob. Chemother. pmid:12039899
Neumann FJ Chlamydia pneumoniae-atherosclerosis link: a sound concept in search for clinical relevance. 2002 Circulation pmid:12417534
Skerk V et al. Comparative analysis of azithromycin and clarithromycin efficacy and tolerability in the treatment of chronic prostatitis caused by Chlamydia trachomatis. 2002 J Chemother pmid:12420857
Sieper J and Braun J [Diagnosis and antibiotic treatment of reactive arthritis]. 2002 Dtsch. Med. Wochenschr. pmid:12226789
Chandrupatla S et al. Azithromycin-induced intrahepatic cholestasis. 2002 Dig. Dis. Sci. pmid:12395890
Steinberg JM and Srugo I Reoccurrence of culture-positive pertussis in an infant initially treated with azithromycin and steroids. 2002 Arch Pediatr Adolesc Med pmid:12361458
Hauben M and Amsden GW The association of erythromycin and infantile hypertrophic pyloric stenosis: causal or coincidental? 2002 Drug Saf pmid:12381214
Duff P Antibiotic selection in obstetrics: making cost-effective choices. 2002 Clin Obstet Gynecol pmid:11862059
Wolter J et al. Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial. 2002 Thorax pmid:11867823
Zhou F et al. High accuracy mass measurement of peptides with internal calibration using a dual electrospray ionization sprayer system for protein identification. 2002 Rapid Commun. Mass Spectrom. pmid:11870887
Corbu C et al. [Ocular toxoplasmosis and consecutive complicated cataract]. 2002 Oftalmologia pmid:12677800
Cascio A et al. Clarithromycin versus azithromycin in the treatment of Mediterranean spotted fever in children: a randomized controlled trial. 2002 Clin. Infect. Dis. pmid:11740701
Schachter J and Dawson CR Elimination of blinding trachoma. 2002 Curr. Opin. Infect. Dis. pmid:12686881
Rapp RP Clinical and economic outcomes in respiratory tract infections: The impact of bacterial resistance. 2002 Postgrad Med pmid:19667590
Kutlin A et al. Effect of prolonged treatment with azithromycin, clarithromycin, or levofloxacin on Chlamydia pneumoniae in a continuous-infection Model. 2002 Antimicrob. Agents Chemother. pmid:11796350
Strle F and Maraspin V Is azithromycin treatment associated with prolongation of the Q-Tc interval? 2002 Wien. Klin. Wochenschr. pmid:12708094
Dawson CR and Schachter J Should trachoma be treated with antibiotics? 2002 Lancet pmid:11812548
Dai G et al. [Researching some sensitivity factor of bioassay method on the antibiotics pharmacokinetics]. 2002 Hunan Yi Ke Da Xue Xue Bao pmid:12575254
Dzelalija B et al. Randomized trial of azithromycin in the prophylaxis of Mediterranean spotted fever. 2002 Acta Med Croatica pmid:12596623
Nalbanski B and Nalbanski A [Treatment of Chlamydia trachomatis with azatril]. 2002 Akush Ginekol (Sofiia) pmid:11935692
Krumov G et al. [Treatment of chlamydial cervicitis with azatril]. 2002 Akush Ginekol (Sofiia) pmid:11935693